Combined use of nuclear phosphoprotein c-Myc and cellular phosphoprotein p53 for hepatocellular carcinoma detection in high-risk chronic hepatitis C patients-Reference-Cited by-同舟云学术

Combined use of nuclear phosphoprotein c-Myc and cellular phosphoprotein p53 for hepatocellular carcinoma detection in high-risk chronic hepatitis C patients

Published:2017-07-13 Issue:4 Volume:74 Page:170-175
ISSN:0967-4845
Container-title:British Journal of Biomedical Science
language:en
Short-container-title:British Journal of Biomedical Science

Author:

Attallah AM¹,El-Far M²,Abdelrazek MA¹,Omran MM³,Attallah AA¹,Elkhouly AA¹,Elkenawy HM¹,Farid K⁴

Affiliation:

1. Biotechnology Research Center, Industrial Zone, New Damietta, Egypt

2. Chemistry Department, Faculty of Science, Mansoura University, Mansoura, Egypt

3. Chemistry Department, Faculty of Science, Helwan University, Cairo, Egypt

4. Tropical Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt

Publisher

Frontiers Media SA

Subject

Infectious Diseases,Biochemistry (medical),Microbiology (medical),Clinical Biochemistry,Immunology,Microbiology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/09674845.2017.1334739

Reference37 articles.

1. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients

2. Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy

3. Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis

4. Association between hepatitis C and hepatocellular carcinoma

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C virus may accelerate breast cancer progression by increasing mutant p53 and c-Myc oncoproteins circulating levels;Breast Cancer;2023-11-16

2. Hepatitis C virus may accelerate breast cancer progression by increasing mutant p53 and c-Myc oncoproteins circulating levels;2023-06-29

3. Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis;Biomedicines;2023-06-28

4. The Clinicopathologic and Prognostic Significance of c-Myc Expression in Hepatocellular Carcinoma: A Meta-Analysis;Frontiers in Bioinformatics;2021-10-12

5. Value of anti-p53 antibody as a biomarker for hepatocellular carcinoma;Medicine;2020-08-21